Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 3 5Phase 2 2Phase 2/3 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 522Leukemia, Myeloid, Acute 498Neoplasms 380Carcinoma, Non-Small-Cell Lung 379Pancreatic Neoplasms 328Precursor Cell Lymphoblastic Leukemia-Lymphoma 318Multiple Myeloma 311Glioblastoma 311Melanoma 309Prostatic Neoplasms 293Leukemia 288Neoplasm Metastasis 284Brain Neoplasms 275Lymphoma 271Lung Neoplasms 269Recurrence 266Ovarian Neoplasms 247Colorectal Neoplasms 246Lymphoma, Non-Hodgkin 241Leukemia, Lymphocytic, Chronic, B-Cell 231Myelodysplastic Syndromes 208Glioma 208Lymphoma, Large B-Cell, Diffuse 186Carcinoma, Hepatocellular 173Lymphoma, Follicular 167Head and Neck Neoplasms 161Hodgkin Disease 160Lymphoma, Mantle-Cell 155Burkitt Lymphoma 154Sarcoma 150

Interventions

substance P-saporin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Pain, Intractable × Clear all
NCT02036281 2018-05-15

A Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable Pain

University of Texas Southwestern Medical Center

Phase 1 Completed
23 enrolled

Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡